Results 221 to 230 of about 36,491,622 (296)

Hepatitis C viral variants bear signatures of de novo CD8+ T cell and antibody pressure after spontaneous postpartum viral suppression. [PDF]

open access: yesProc Natl Acad Sci U S A
Phelps CC   +10 more
europepmc   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

open access: yesMolecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir   +9 more
wiley   +1 more source

GLP-1 Receptor Agonist and Bariatric Surgery Utilization Among Adolescents and Young Adults.

open access: yesJAMA Pediatr
Messiah SE   +10 more
europepmc   +1 more source

Differential methanogenic archaea-induced TLR8-dependent signaling engages gene classes regulated by NF-κB p65 and STAT1/2. [PDF]

open access: yesNat Commun
Xu F   +7 more
europepmc   +1 more source

Patterns of perceptions and beliefs about PrEP and their association with daily oral PrEP initiation among sexual and gender diverse adolescents in Brazil. [PDF]

open access: yesCad Saude Publica
Seixas S   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy